CAS: 1345982-69-5
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
GSK 2330672 REF: AN-AG009CBXCAS: 1345982-69-5 | 98% | 160.00 €~1,622.00 € | Wed 08 May 24 | |
Linerixibat REF: TM-T3978CAS: 1345982-69-5 | 99.83% | 82.00 €~832.00 € | Wed 15 May 24 | |
Linerixibat REF: 4Z-L-217001CAS: 1345982-69-5 | - - - | To inquire | Wed 15 May 24 | |
Linerixibat REF: 3D-VDC98269CAS: 1345982-69-5 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG009CBX
1mg | 160.00 € | |
2mg | 243.00 € | |
5mg | 583.00 € | |
10mg | 690.00 € | |
25mg | 1,086.00 € | |
50mg | 1,622.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
Linerixibat
CAS:1345982-69-5
Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor (IC50: 42 ± 3 nM). It …
Formula:
C28H38N2O7S
Purity:
99.83%
Color and Shape:
Solid
Molecular weight:
546.68
Ref: TM-T3978
1mg | 82.00 € | |
2mg | 115.00 € | |
5mg | 207.00 € | |
10mg | 348.00 € | |
25mg | 588.00 € | |
50mg | 832.00 € | |
1ml*10 (DMSO) | 250.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
Ref: 4Z-L-217001
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 May 2024
Linerixibat
CAS:1345982-69-5
Linerixibat is a drug that has been shown to reduce the accumulation of fat in …
Formula:
C28H38N2O7S
Purity:
Min. 95%
Molecular weight:
546.68 g/mol
Ref: 3D-VDC98269
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024